Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Use this ZVRA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ZVRA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ZVRA SEC filings page. Lician reads the product cache first so this HTML stays unique to Zevra Therapeutics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full ZVRA income, balance, and cash tables.